Mutant KRAS is a druggable target for pancreatic cancer (Q37409321)
Jump to navigation
Jump to search
scientific article published on 02 December 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mutant KRAS is a druggable target for pancreatic cancer |
scientific article published on 02 December 2013 |
Statements
1 reference
Mutant KRAS is a druggable target for pancreatic cancer (English)
1 reference
Elina Zorde Khvalevsky
1 reference
Racheli Gabai
1 reference
Itzhak Haim Rachmut
1 reference
Elad Horwitz
1 reference
Zivia Brunschwig
1 reference
Ariel Orbach
1 reference
Adva Shemi
1 reference
Talia Golan
1 reference
Abraham J Domb
1 reference
Eylon Yavin
1 reference
Hilla Giladi
1 reference
Ludmila Rivkin
1 reference
Alina Simerzin
1 reference
Rami Eliakim
1 reference
Abed Khalaileh
1 reference
Ayala Hubert
1 reference
Maor Lahav
1 reference
Yael Kopelman
1 reference
Eran Goldin
1 reference
Alan Dancour
1 reference
Yael Hants
1 reference
Sagit Arbel-Alon
1 reference
Rinat Abramovitch
1 reference
Amotz Shemi
1 reference
1 reference
Identifiers
1 reference